Immune System
|

MalheuR: interdisciplinary study of the coincidence of malignant and rheumatic diseases at the clinical and translational levels

Institution: Department of Internal Medicine V – Hematology, Oncology, and Rheumatology, Heidelberg University Hospital
Applicant: Dr. Karolina Gente
Funding line:
Else Kröner Excellence Fellowships
Image
In the MalheuR consultation, cancer patients with rheumatic diseases receive personalized care and advice based on the latest research findings
(© Eszter Varga, Internal Medicine V, Heidelberg University Hospital)

In the MalheuR project, Karolina Gente and her team are investigating how cancer patients with rheumatic diseases can be given the best possible treatment. Since 2018, more than 1,200 patients in Heidelberg have been registered to enable a systematic analysis of the interactions between cancer and rheumatic diseases. The interdisciplinary research team is using clinical data and blood samples to identify biomarkers that may allow more precise treatment decisions. The goal is to build a solid foundation for personalized treatments with the aim of improving both the medical care and patients’ quality of life. 

Further information: https://www.klinikum.uni-heidelberg.de/kliniken-institute/kliniken/zentrum-fuer-innere-medizin-krehl-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/sektion-rheumatologie/malheur-projekt-maligne-und-rheumatische-erkrankungen-zwei-extreme-des-fehlgesteuerten-immunsystems